Frailty and Anticoagulant Therapy in Patients Aged 65 Years or Older with Atrial Fibrillation

Frailty and Anticoagulant Therapy in Patients Aged 65 Years or Older with Atrial Fibrillation

Background: Elderly adults with atrial fibrillation (AF) are at increased risk of frailty and thromboembolic complications. However, studies on the prevalence of frailty in AF patients and data on the relationship between frailty and the use of anticoagulants are limited. Methods: We conducted a cro...

Full description

Bibliographic Details
Main Authors: Jiapeng Liu, MD, Xin Du, MD, Mengmeng Li, MD, Zhaoxu Jia, MD, Shangxin Lu, MD, Sanshuai Chang, MD, Ribo Tang, MD, Rong Bai, MD, Jianzeng Dong, MD, Gregory Y. H. Lip, MD, Changsheng Ma, MD
Format: Article
Language:English
Published: Compuscript 2020-01-01
Series:Cardiovascular Innovations and Applications
Subjects:
atrial fibrillation
frailty
anticoagulant
elderly adults
Online Access:https://www.ingentaconnect.com/content/cscript/cvia/2020/00000004/00000003/art00001

Internet

https://www.ingentaconnect.com/content/cscript/cvia/2020/00000004/00000003/art00001

Similar Items